University of Aberdeen logo

AURA - Aberdeen University Research Archive

 

Blood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Force

dc.contributor.authorAngioni, Davide
dc.contributor.authorDelrieu, J.
dc.contributor.authorHansson, O.
dc.contributor.authorFillit, H.
dc.contributor.authorAisen, P.
dc.contributor.authorCummings, J.
dc.contributor.authorSims, J. R.
dc.contributor.authorBraunstein, J. B.
dc.contributor.authorSabbagh, M.
dc.contributor.authorBittner, T.
dc.contributor.authorPontecorvo, M.
dc.contributor.authorBozeat, S.
dc.contributor.authorDage, J. L.
dc.contributor.authorLargent, E.
dc.contributor.authorMattke, S.
dc.contributor.authorCorrea, O.
dc.contributor.authorGutierrez Robledo, L. M.
dc.contributor.authorBaldivieso, V.
dc.contributor.authorWillis, D. R.
dc.contributor.authorAtri, A.
dc.contributor.authorBateman, R. J.
dc.contributor.authorOusset, P. J.
dc.contributor.authorVellas, B.
dc.contributor.authorWeiner, M.
dc.contributor.authorEU/US/CTAD Task Force
dc.contributor.institutionUniversity of Aberdeen.Medical Sciencesen
dc.date.accessioned2023-06-27T14:47:01Z
dc.date.available2023-06-27T14:47:01Z
dc.date.issued2022-10-12
dc.descriptionAdditional information Task force members: Sandrine Andrieu (Toulouse, France), Phyllis Barkman Ferrell (Indianapolis, USA), Russell Barton (Baltimore, USA), Monika Baudler (Basel, Switzerland), Navia Bradford (Cambridge, USA), Brady Burgess (San Francisco, USA), Brian Campbell (San Francisco, USA), Chris Dague (Malvern, USA), Francesca De Simone (Malvern, USA), Robert Dean (Indianiapolis, USA), Jean-Cosme Dodart (Dallas, USA), Rachelle Doody (Basel, Switzerland), Kristen Eisterhold (Indianapolis, USA), Stephane Epelbaum (Indianapolis, USA), Sven Eriksson (Stockholm, Sweden), Rianne Esquvel (Malvern, USA), Michela Gallagher (Baltimore, USA), Hideki Garren (San Francisco, USA), Sarah Giardina (New York, USA), Ishtar Govia (Kingston, Jamaica), Virginie Gregoire (Indianapolis, USA), Harald Hampel (Nutley, USA), Charles Harrington (Aberdeen, United Kingdom), James Hendrix (Indianapolis, USA), Dave Henley (Titusville, USA), Joseph Herring (North Wales, USA), Helen Hu (Nutley, USA), Farhad Imam (Kirkland, USA), Michael Irizarry (Nutley, USA), Peter Johannsen (Bagsvaerd, Denmark), Paul Kinnon (Solana Beach, USA), Hartmuth Kolb (Titusville, USA), Hisatomo Kowa (Kobe, Japan), Akihiko Koyama (Nutley, USA), Lynn Kramer (Nutley, USA), Lars Lannfelt (Uppsala, Sweden), John Lawson (Malvern, USA), Ferenc Martenyi (San Francisco, USA), Sarah McManus (Titusville, USA), David Miller (Blue Bell, USA), Sonya Miller (Aberdeen, United Kingdom), Richard Mohs (Baltimore, USA), Laura Nisenbaum (New York, USA), Gunilla Osswald (Stockholm, Sweden), Suzanne Ostrowitzki (San Francisco, USA), Lewis Penny (Aberdeen, United Kingdom), Elizabeth Pittampalli (San Francisco, USA), Craig Ritchie (Edinburgh, United Kingdom), Andrew Roche (Dublin, Ireland), Yves Rolland (Toulouse, France), Sharon Rosenzweig-Lipson (Baltimore, USA), Peter Schuler (Langen, Germany), Maria Eugenia Soto Martin (Toulouse), Reisa Sperling (Boston, USA), Erik Stoops (Gent, Belgium), Aishwarya Sukumar (Kirkland, USA), Charlotte Thim Hansen (Bagsvaerd, Denmark), Jacques Touchon (Montpellier, France), Martin Traber (Basel, Switzerland), Gallen Triana-Baltzer (Titusville, USA), Eugeen Vanmechelen (Gent, Belgium), Huijing Yu (Dallas, USA), Wagner Zago (San Francisco, USA), Nancy Zhang (Titusville, USA).en
dc.description.statusPeer revieweden
dc.format.extent11
dc.format.extent4021542
dc.identifier246410280
dc.identifier46864cff-6f39-49e4-97f5-7b93c5ec7414
dc.identifier85140235833
dc.identifier36281661
dc.identifier.citationAngioni, D, Delrieu, J, Hansson, O, Fillit, H, Aisen, P, Cummings, J, Sims, J R, Braunstein, J B, Sabbagh, M, Bittner, T, Pontecorvo, M, Bozeat, S, Dage, J L, Largent, E, Mattke, S, Correa, O, Gutierrez Robledo, L M, Baldivieso, V, Willis, D R, Atri, A, Bateman, R J, Ousset, P J, Vellas, B, Weiner, M & EU/US/CTAD Task Force 2022, 'Blood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Force', Journal of Prevention of Alzheimer's Disease, vol. 9, no. 4, pp. 569-579. https://doi.org/10.14283/jpad.2022.85en
dc.identifier.doi10.14283/jpad.2022.85
dc.identifier.iss4en
dc.identifier.issn2274-5807
dc.identifier.otherORCID: /0000-0002-3722-4476/work/136883025
dc.identifier.urihttps://hdl.handle.net/2164/21030
dc.identifier.urlhttp://www.scopus.com/inward/record.url?scp=85140235833&partnerID=8YFLogxKen
dc.identifier.vol9en
dc.language.isoeng
dc.relation.ispartofJournal of Prevention of Alzheimer's Diseaseen
dc.subjectSDG 3 - Good Health and Well-beingen
dc.subjectAlzheimer’s diseaseen
dc.subjectamyloiden
dc.subjectblood biomarkersen
dc.subjectclinical trialsen
dc.subjectdiagnosticen
dc.subjectneurofilament lighten
dc.subjectp-tauen
dc.subjectClinical Neurologyen
dc.subjectPsychiatry and Mental healthen
dc.titleBlood Biomarkers from Research Use to Clinical Practice : What Must Be Done? A Report from the EU/US CTAD Task Forceen
dc.typeJournal articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Angioni_etal_JPAD_BloodBiomarkersFrom_VOR.pdf
Size:
3.84 MB
Format:
Adobe Portable Document Format

Collections